GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ranbaxy Laboratories Ltd (LSE:RBXD) » Definitions » DeferredTaxAndRevenue

Ranbaxy Laboratories (LSE:RBXD) DeferredTaxAndRevenue : $0.0 Mil (As of Sep. 2014)


View and export this data going back to . Start your Free Trial

What is Ranbaxy Laboratories DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Ranbaxy Laboratories's current deferred tax and revenue for the quarter that ended in Sep. 2014 was $0.0 Mil.

Ranbaxy Laboratories DeferredTaxAndRevenue Historical Data

The historical data trend for Ranbaxy Laboratories's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ranbaxy Laboratories DeferredTaxAndRevenue Chart

Ranbaxy Laboratories Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11
DeferredTaxAndRevenue
Get a 7-Day Free Trial - - - - -

Ranbaxy Laboratories Quarterly Data
Dec11 Dec12 Jun13 Sep14
DeferredTaxAndRevenue - - - -

Ranbaxy Laboratories DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Ranbaxy Laboratories's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ranbaxy Laboratories (LSE:RBXD) Business Description

Traded in Other Exchanges
N/A
Address
Ranbaxy Laboratories Ltd., is an integrated international pharmaceuticals company. It markets, produces and distributes pharmaceuticals products.

Ranbaxy Laboratories (LSE:RBXD) Headlines

No Headlines